Artie Suckow, DTx Pharma CEO

No­var­tis to buy siR­NA de­vel­op­er DTx Phar­ma for up to $1B

No­var­tis will con­tin­ue to add siR­NA ca­pa­bil­i­ties to its tool belt in a deal worth up to $1 bil­lion.

The Swiss phar­ma

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.